2 weeks Tilray’s stock slumps as cannabis and beer company plans to cut its drinks lineup MarketWatch X
4 weeks US Delta-9 THC Markets And German Medical Cannabis Synergize Tilray’s Potential Seeking Alpha X
1 month Organigram: Long Term Growth Improving With International And Domestic Cannabis Expansion (Rating Upgrade) Seeking Alpha X
1 month Weedmaps founders want to take the company private as cannabis sector runs into headwinds MarketWatch X
1 month Canada’s Organigram shops for U.S. pot businesses with backing from British American Tobacco MarketWatch X
2 months NewLake Capital Partners: Hold Out For This Cannabis-Driven REIT With Immense Potential Seeking Alpha X
2 months OrganiGram purchasing Motif Labs to become Canada’s largest cannabis company by market share, as others retreat MarketWatch X
2 months Hemp-based THC revenue may make cannabis stocks more appealing—but there are risks MarketWatch X
2 months Advanced Flower Capital: Get Paid 13.7% Per Year As The Cannabis Market Grows Seeking Alpha X
2 months While legalizing marijuana is in limbo, FDA clears a PTSD study that could boost cannabis stocks over time MarketWatch X
2 months Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy + Seeking Alpha X
2 months Trump AG pick Gaetz could be great for cannabis — but stock moves suggest confirmation is unlikely MarketWatch X
2 months Cannabis stock valuations and investments hobbled by regulatory uncertainties, experts say MarketWatch X
3 months Cannabis company vows to sue after New Mexico destroys tens of thousands of pounds of its marijuana crop Fortune X
3 months Breaking the Grass Ceiling: Pot firms rethink strategy as young women lead cannabis use Investing.com X
3 months Navigating Volatility: MSOS ETF’s Prospects In A Shifting Cannabis Landscape Seeking Alpha X